Gregg Beloff

Gregg D.
Beloff is the founder of Danforth Advisors LLC, established in 2011, where the title held is Co-Managing Director.
Current jobs include Director at SG DAN Holdings LLC, President & Director at Danforth Health, Inc., Director at Formation Biologics Corp., Director at 35Pharma, Inc., Chief Financial Officer at Neurovance, Inc., and Chief Financial Officer at Pandion Therapeutics, Inc. Former jobs include Director at Bristol-Myers Squibb FCT bêta, Inc. (2018–2020), Chief Financial Officer at ImmunoGen, Inc. (2001–2003), Chief Financial Officer at Archemix Corp.
(2003–2009), Chief Financial Officer at Cerulean Pharma, Inc., Chief Financial Officer at Seres Therapeutics, Inc., Chief Financial Officer at Syros Pharmaceuticals, Inc. (2012–2014), Chief Financial Officer at Synlogic, Inc. (2019–2022), Attorney at Gaffin & Krattenmaker PC, and Chief Financial Officer at Gemini Therapeutics, Inc. Education includes an MBA from Carnegie Mellon University, undergraduate studies at Middlebury College, and graduate studies at the University of Pittsburgh Law School.